Purchases and Sales Made in Q4 2024 in Tarsus Pharmaceuticals, Inc. (TARS)
This table provides information about the institutional ownership of Tarsus Pharmaceuticals, Inc. (TARS) during Q4 2024. The information is specifically focused on institutions that hold shares of Tarsus Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 12, 2025
Q4 2024
|
Artisan Partners Limited Partnership
Milwaukee, WI |
SELL
|
- |
-17.7K- 2.5% |
$572K - $981K
|
691K
$35.8M
|
|
|
Feb 13, 2025
Q4 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-24K- 24.32% |
$774K - $1.33M
|
74.7K
$3.86M
|
|
|
Feb 14, 2025
Q4 2024
|
Integral Health Asset Management, LLC
|
SELL
|
- |
-25K- 6.67% |
$807K - $1.38M
|
350K
$18.1M
|
|
|
Feb 07, 2025
Q4 2024
|
Essex Investment Management CO LLC
Boston, MA |
SELL
|
- |
-29.4K- 26.93% |
$949K - $1.63M
|
79.8K
$4.13M
|
|
|
Jan 29, 2025
Q4 2024
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-29.4K- 13.97% |
$949K - $1.63M
|
181K
$9.37M
|
|
|
Feb 14, 2025
Q4 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-51.3K- 89.53% |
$1.66M - $2.84M
|
6K
$311K
|
|
|
Feb 13, 2025
Q4 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-62.7K- 15.51% |
$2.02M - $3.47M
|
341K
$17.7M
|
|
|
Feb 14, 2025
Q4 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-119K- 43.24% |
$3.85M - $6.6M
|
156K
$8.09M
|
|
|
Feb 14, 2025
Q4 2024
|
Ally Bridge Group (Ny) LLC
New York, NY |
SELL
|
- |
-149K- 46.21% |
$4.8M - $8.24M
|
173K
$8.96M
|
|
|
Feb 14, 2025
Q4 2024
|
Rtw Investments, LP
New York, NY |
SELL
|
- |
-176K- 5.16% |
$5.68M - $9.74M
|
3.24M
$167M
|
|
|
Feb 14, 2025
Q4 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-178K- 94.77% |
$5.73M - $9.84M
|
9.8K
$507K
|
|
|
Feb 14, 2025
Q4 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-203K- 79.13% |
$6.55M - $11.2M
|
53.5K
$2.77M
|
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-205K- 69.2% |
$6.61M - $11.3M
|
91.2K
$4.72M
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-240K- 10.84% |
$7.73M - $13.3M
|
1.97M
$102M
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-305K- 79.36% |
$9.85M - $16.9M
|
79.3K
$4.11M
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-311K- 70.65% |
$10M - $17.2M
|
129K
$6.68M
|
|
|
Feb 14, 2025
Q4 2024
|
Tfg Asset Management Gp LTD
Grand Cayman, E9 |
SELL
|
- |
-414K- 67.43% |
$13.4M - $22.9M
|
200K
$10.3M
|
|
|
Feb 14, 2025
Q4 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-423K- 41.02% |
$13.6M - $23.4M
|
608K
$31.4M
|
|
|
Feb 14, 2025
Q4 2024
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-427K- 76.65% |
$13.8M - $23.7M
|
130K
$6.74M
|
|
|
Feb 14, 2025
Q4 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-1.11M- 85.6% |
$35.8M - $61.4M
|
187K
$9.66M
|